Relay Therapeutics (RLAY) Receivables (2020 - 2023)
Relay Therapeutics (RLAY) posted quarterly Receivables of $211000.0 for Q3 2023, down 95.69% year-over-year from $4.9 million in Q3 2022, and up 170.51% quarter-over-quarter from $78000.0 in Q2 2023.
Powered by 
Analysis
Relay Therapeutics (RLAY) Receivables (2020 - 2023) Analysis & Trends
Relay Therapeutics (RLAY) has reported Receivables for 4 consecutive years, with $211000.0 the latest figure, recorded in Q3 2023.
- In Q3 2023, Receivables fell 95.69% year-over-year to $211000.0; the TTM figure through Sep 2023 stood at $211000.0 (down 95.69% YoY), while the FY2022 annual figure was $306000.0, down 93.26% from the prior year.
- Receivables improved to $211000.0 in Q3 2023 per RLAY's latest filing, from $78000.0 in the prior quarter.
- Across five years, Receivables topped out at $75.0 million in Q4 2020 and bottomed at $78000.0 in Q2 2023.
- Historically, Receivables has averaged $9.3 million across 4 years, with a median of $4.4 million in 2021.
- Annual changes were most pronounced in 2022 — Receivables advanced 15.27% — and 2023, when it plunged 95.69%.
- Relay Therapeutics' Receivables stood at $75.0 million in 2020, then tumbled by 93.95% to $4.5 million in 2021, then sank by 93.26% to $306000.0 in 2022, then sank by 31.05% to $211000.0 in 2023.
- Business Quant data shows RLAY's Receivables at $211000.0 in Q3 2023, $78000.0 in Q2 2023, and $4.9 million in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 160.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.06 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 912.74 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Relay Therapeutics | 3.87 Bn | 3.87 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 211,000.00 |
| Jun 30, 2023 | 78,000.00 |
| Mar 31, 2023 | 4.95 Mn |
| Dec 31, 2022 | 4.91 Mn |
| Sep 30, 2022 | 4.90 Mn |
| Jun 30, 2022 | 4.80 Mn |
| Mar 31, 2022 | 4.70 Mn |
| Dec 31, 2021 | 4.54 Mn |
| Sep 30, 2021 | 4.25 Mn |
| Jun 30, 2021 | 4.19 Mn |
| Mar 31, 2021 | 8.61 Mn |
| Dec 31, 2020 | 75.00 Mn |